The incidence and distribution of mediastinal lymph node metastasis and its impact on survival in patients with non-small-cell lung cancers 3 cm or less: data from 2292 cases
- 18 January 2019
- journal article
- research article
- Published by Oxford University Press (OUP) in European Journal of Cardio-Thoracic Surgery
- Vol. 56 (1), 159-166
- https://doi.org/10.1093/ejcts/ezy479
Abstract
OBJECTIVES Our goal was to investigate the incidence and distribution of mediastinal lymph node metastases (MLNM) in non-small-cell lung cancers (NSCLC) 3 cm or less, with the purpose of guiding mediastinal lymph node dissection. METHODS A total of 2292 cases seen between January 2001 and December 2014 were included. These patients were grouped according to the lobes with the primary tumours. The incidence and distribution of pathological MLNM were compared among the groups. The impact of MLNM on overall survival was also compared. RESULTS The most common mediastinal metastatic sites for different primary tumour lobes were as follows: right upper lobe, 17.7% (87/492) for level 4R; right middle lobe, 14.9% (28/188) for level 7; right lower lobe, 19.8% (82/414) for level 7; left upper lobe, 18.2% (96/528) for level 5; and left lower lobe, 16.6% (42/253) for level 7. For patients with tumours in the upper lobe, the median survival time was 32 months for those with MLNM in the subcarinal zone or lower zone compared with 83 months for those with MLNM only in the upper zone (P < 0.01). When the tumours were 1 cm or less, the incidence of MLNM to the lower zone for upper lobe tumours and of MLNM to the upper zone for lower lobe tumours was zero. CONCLUSIONS Different primary NSCLC lobe locations have a different propensity to be sites of MLNM for those tumours that are 3 cm or less. For tumours no larger than 1 cm, a lower zone mediastinal lymph node dissection might be unnecessary for upper lobe tumours and an upper zone mediastinal lymph node dissection might be unnecessary for lower lobe tumours.Keywords
Funding Information
- Science and Technology Planning Project of Guangdong Province (2013B021800147)
- Natural Science Foundation of Guangdong Province (2016A030313857, 2018A030313410)
- Guangdong Provincial Medical Scientific Funds (2016114134515565)
- National Natural Science Foundation of China (81501986)
This publication has 29 references indexed in Scilit:
- Retrospective Analysis of Nodal Spread Patterns According to Tumor Location in Pathological N2 Non‐small Cell Lung CancerWorld Journal of Surgery, 2012
- Skip Mediastinal Nodal Metastases in the IIIa/N2 Non-Small Cell Lung CancerJournal of Thoracic Oncology, 2007
- Distribution and Likelihood of Lymph Node Metastasis Based on the Lobar Location of Nonsmall-Cell Lung CancerThe Annals of Thoracic Surgery, 2006
- Selective Mediastinal Lymphadenectomy for Clinico-Surgical Stage I Non–Small Cell Lung CancerThe Annals of Thoracic Surgery, 2006
- Does the extent of lymph node dissection influence outcome in patients with stage I non-small-cell lung cancer?European Journal of Cardio-Thoracic Surgery, 2005
- Skip mediastinal nodal metastases in non-small cell lung cancer1European Journal of Cardio-Thoracic Surgery, 2004
- Involvement of lymphatic metastatic spread in non-small cell lung cancer accordingly to the primary cancer locationLung Cancer, 2004
- Skip metastasis in nonsmall cell lung carcinomaCancer, 2004
- A randomized trial of systematic nodal dissection in resectable non-small cell lung cancerLung Cancer, 2002
- Effectiveness of Radical Systematic Mediastinal Lymphadenectomy in Patients With Resectable Non-Small Cell Lung CancerAnnals of Surgery, 1998